TrialAnnals of neurology2021
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Dean M Wingerchuk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papertrialcites it
TrialAnnals of neurology2021
Dean M Wingerchuk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.